Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

XORTX Therapeutics Inc.

1.10
+0.250029.41%
Post-market: 0.7600-0.3400-30.91%19:59 EDT
Volume:112.31M
Turnover:140.86M
Market Cap:5.73M
PE:-2.00
High:1.41
Open:1.17
Low:1.01
Close:0.8500
52wk High:2.03
52wk Low:0.6608
Shares:5.21M
Float Shares:4.92M
Volume Ratio:2,015.81
T/O Rate:2282.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5507
EPS(LYR):-1.1511
ROE:-79.44%
ROA:-42.15%
PB:2.82
PE(LYR):-0.96

Loading ...

OverviewCompanyNewsFilings

Why Is XORTX Therapeutics Stock (XRTX) Up 20% Today?

TIPRANKS
·
Oct 17

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

GlobeNewswire
·
Oct 17

Xortx Therapeutics files to sell 4.76M common shares

TIPRANKS
·
Sep 26

XORTX Initiates IND Preparation for XORLO™ in Gout Program

GlobeNewswire
·
Sep 03

XORTX Completes USD $114,500 Private Placement

GlobeNewswire
·
Aug 09

XORTX Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
Aug 09

XORTX Announces USD $114,500 Private Placement

GlobeNewswire
·
Jul 31

XORTX Completes Non-Brokered Private Placement of Units

GlobeNewswire
·
Jul 23

XORTX Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
May 17

XORTX Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
May 13

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 14, 2025 Post Market
Financial Report Announcement
May 15, 2025 Post Market
Financial Report Announcement
Mar 31, 2025 Post Market
Financial Report Announcement
Nov 14, 2024 Post Market
Financial Report Announcement
Aug 14, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.00
Current
-5.45
Sector Average
60.10%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.00
Maximum
7.40
+1 STD
1.73
Minimum
-30.13
-1 STD
-12.63
Average
-5.45

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.